Machine-learning-based exploration to identify remodeling patterns associated with death or heart-transplant in

Patricia Garcia-Canadilla1, Sergio Sanchez-Martinez1, Pablo M Martí-Castellote2

  • 1Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, Spain.

Insights

Interpretable machine learning identified distinct patient groups in pediatric dilated cardiomyopathy (DCM). Certain phenotypes, particularly those with severe heart failure, showed a higher risk of death or heart transplant (DoT).

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Machine Learning in Medicine

Background:

  • Pediatric dilated cardiomyopathy (DCM) is a complex condition affecting heart function.
  • Risk stratification for adverse outcomes like death or heart transplant (DoT) in pediatric DCM is crucial for timely intervention.

Purpose of the Study:

  • To investigate left ventricular (LV) remodeling, mechanics, and function in pediatric DCM using interpretable machine learning.
  • To associate clinical characteristics and heart failure treatment with the risk of DoT in pediatric DCM patients.

Main Methods:

  • Retrospective analysis of echocardiographic and clinical data from pediatric DCM patients and healthy controls.
  • Application of unsupervised multiple kernel learning and k-means clustering for patient phenotyping based on cardiac function and clinical data.
  • Evaluation of the proportion of patients experiencing DoT within identified phenotypic groups.

Main Results:

  • Five distinct patient groups were identified, with healthy controls clustering separately from DCM patients.
  • Cluster-5, comprising older, highly medicated patients with combined systolic and diastolic heart failure, had the highest DoT proportion.
  • Cluster-4 showed severe LV remodeling and systolic dysfunction with a high DoT risk, while Cluster-3 had moderate dysfunction and the lowest DoT risk.

Conclusions:

  • Interpretable machine learning can identify pediatric DCM patients at high risk for DoT.
  • This approach aids in delineating mechanisms associated with DoT risk, potentially improving prognostication and treatment strategies.
  • Full cardiac-cycle data, mechanics, and clinical parameters are valuable for risk stratification in pediatric DCM.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
52
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
57
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
80
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
42